John G Ullman & Associates Inc. Increases Stock Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

John G Ullman & Associates Inc. grew its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 8.7% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 129,730 shares of the medical instruments supplier’s stock after purchasing an additional 10,400 shares during the quarter. John G Ullman & Associates Inc.’s holdings in DENTSPLY SIRONA were worth $4,617,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in XRAY. Ninety One UK Ltd increased its stake in shares of DENTSPLY SIRONA by 16.1% in the 4th quarter. Ninety One UK Ltd now owns 1,201,198 shares of the medical instruments supplier’s stock worth $42,751,000 after acquiring an additional 166,963 shares in the last quarter. Avior Wealth Management LLC increased its stake in shares of DENTSPLY SIRONA by 18.6% in the 4th quarter. Avior Wealth Management LLC now owns 26,800 shares of the medical instruments supplier’s stock worth $954,000 after acquiring an additional 4,200 shares in the last quarter. Louisiana State Employees Retirement System bought a new position in shares of DENTSPLY SIRONA in the 4th quarter worth about $456,000. International Assets Investment Management LLC bought a new position in shares of DENTSPLY SIRONA in the 4th quarter worth about $782,000. Finally, Cambiar Investors LLC increased its stake in shares of DENTSPLY SIRONA by 15.2% in the 4th quarter. Cambiar Investors LLC now owns 323,432 shares of the medical instruments supplier’s stock worth $11,511,000 after acquiring an additional 42,685 shares in the last quarter. 95.70% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several brokerages recently commented on XRAY. StockNews.com raised shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research report on Friday, January 19th. Needham & Company LLC reaffirmed a “buy” rating and set a $42.00 price target on shares of DENTSPLY SIRONA in a report on Thursday, February 29th. Piper Sandler raised their price target on shares of DENTSPLY SIRONA from $31.00 to $35.00 and gave the company a “neutral” rating in a report on Friday, January 12th. Barrington Research reaffirmed an “outperform” rating and set a $41.00 price target on shares of DENTSPLY SIRONA in a report on Thursday. Finally, Leerink Partnrs reissued an “outperform” rating on shares of DENTSPLY SIRONA in a report on Monday, February 26th. Three research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $39.50.

DENTSPLY SIRONA Price Performance

Shares of NASDAQ:XRAY traded up $0.06 during midday trading on Friday, reaching $30.50. 1,841,611 shares of the company’s stock traded hands, compared to its average volume of 3,389,659. The company has a fifty day simple moving average of $32.84 and a two-hundred day simple moving average of $32.87. DENTSPLY SIRONA Inc. has a 1 year low of $26.27 and a 1 year high of $43.24. The company has a debt-to-equity ratio of 0.55, a quick ratio of 0.95 and a current ratio of 1.38. The company has a market cap of $6.32 billion, a P/E ratio of -49.10, a PEG ratio of 1.23 and a beta of 0.98.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its earnings results on Thursday, February 29th. The medical instruments supplier reported $0.44 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.43 by $0.01. DENTSPLY SIRONA had a positive return on equity of 11.14% and a negative net margin of 3.33%. The business had revenue of $1.01 billion during the quarter, compared to the consensus estimate of $972.61 million. During the same period last year, the company earned $0.46 EPS. The company’s revenue for the quarter was up 3.0% on a year-over-year basis. Equities analysts predict that DENTSPLY SIRONA Inc. will post 2.05 EPS for the current fiscal year.

DENTSPLY SIRONA Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, April 12th. Stockholders of record on Friday, March 29th were issued a dividend of $0.16 per share. The ex-dividend date of this dividend was Wednesday, March 27th. This is a boost from DENTSPLY SIRONA’s previous quarterly dividend of $0.14. This represents a $0.64 dividend on an annualized basis and a dividend yield of 2.10%. DENTSPLY SIRONA’s dividend payout ratio is currently -103.23%.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.